EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

28.00p
   
  • Change Today:
      0.40p
  • 52 Week High: 31.90
  • 52 Week Low: 18.75
  • Currency: UK Pounds
  • Shares Issued: 446.44m
  • Volume: 28,359
  • Market Cap: £125.00m

EKF Overview

EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.
Competitors: Physiomics, SDI Group , Polarean Imaging
Registrars: Capita Registrars

Key Personnel

CEO: Gavin T Jones
CFO: Stephen (Steve) Young
Executive Chairman: Julian Baines
Senior Independent Director: Christian Alexander Rigg
Non-Executive Dir: Jenny Winter, Christopher H B Mills

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 20 710570
Fax: +44 (0)29 20 705715
Website: http://www.ekfdiagnostics.com

Listings

Sector: Financials(LSE)
Index: FTSE AIM All-Share
ISIN: GB0031509804

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 28.00p
Change Today 0.40p
% Change 1.45 %
52 Week High 31.90
52 Week Low 18.75
Volume 28,359
Shares Issued 446.44m
Market Cap £125.00m

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.32% below the market average90.32% below the market average90.32% below the market average90.32% below the market average90.32% below the market average
89.8% below the sector average89.8% below the sector average89.8% below the sector average89.8% below the sector average89.8% below the sector average
Price Trend
12.36% above the market average12.36% above the market average12.36% above the market average12.36% above the market average12.36% above the market average
28.71% below the sector average28.71% below the sector average28.71% below the sector average28.71% below the sector average28.71% below the sector average
Income Not Available
Growth
61.17% above the market average61.17% above the market average61.17% above the market average61.17% above the market average61.17% above the market average
59.14% above the sector average59.14% above the sector average59.14% above the sector average59.14% above the sector average59.14% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for 21-Oct-2025

Time Volume / Share Price
15:11 1 @ 27.90p
15:10 2 @ 28.00p
15:10 574 @ 27.90p
15:10 4 @ 27.90p
15:05 32 @ 28.00p

EKF Key Personnel

CFO Stephen (Steve) Young
CEO Gavin T Jones

Top of Page